Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy
| dc.contributor.author | Wang, David | |
| dc.contributor.author | Leo, Christopher | |
| dc.contributor.author | Liu, Liping | |
| dc.contributor.author | Huang, Li | |
| dc.contributor.author | Huang, Lisa | |
| dc.contributor.author | Lu, Yun | |
| dc.date.accessioned | 2023-02-19T12:52:36Z | |
| dc.date.available | 2023-02-19T12:52:36Z | |
| dc.date.updated | 2023-02-19T12:52:35Z | |
| dc.identifier.issn | 2059-8688 | |
| dc.identifier.issn | 2059-8696 | |
| dc.identifier.uri | ||
| dc.language | en | |
| dc.publisher | BMJ | |
| dc.relation.ispartof | Stroke and Vascular Neurology | |
| dc.relation.isversionof | 10.1136/svn-2023-002321 | |
| dc.title | Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy | |
| dc.type | Journal article | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Faculty | |
| pubs.publication-status | Published online |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Antithrombotic therapy in patients with COVID-19_indications, pharmacotherapy and controversy.pdf
- Size:
- 218.61 KB
- Format:
- Adobe Portable Document Format